Last reviewed · How we verify
NCT06829706
The Efficacy of Modified Olfactory Training Method for Patients With Post-viral Olfactory Dysfunction
NA trial testing Conventional olfactory training device in Olfactory Dysfunction in 150 participants. Currently enrolling.
22 March 2027
Quick facts
| Lead sponsor | Peking University Third Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 22 March 2025 |
| Primary completion | 22 March 2027 |
| Estimated completion | 22 May 2027 |
| Sites | 1 location across China |
Drugs / interventions tested
- Conventional olfactory training device
- Modified olfactory training device
- Conventional olfactory training device with placebo
Conditions studied
- Olfactory Dysfunction — all drugs for Olfactory Dysfunction →
- Post Viral Olfactory Dysfunction (PVOD) — all drugs for Post Viral Olfactory Dysfunction (PVOD) →
Sponsor
Peking University Third Hospital
Who can join
Adults 18 to 80, any sex, with Olfactory Dysfunction or Post Viral Olfactory Dysfunction (PVOD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to validate the effectiveness of the modified olfactory training device, the main questions it aims to answer are: Is the modified olfactory training device effective in treating patients with post-viral olfactory dysfunction? Compared to the conventional device, how efficient is the modified olfactory training device for improving olfactory function?
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Randomised trial protocol to assess efficacy of modified olfactory training method for patients with postinfectious olfactory dysfunction.
Xie J, Li Y, He H, Liu Y, et al · · 2025 · PMID 41436263 · DOI 10.1136/bmjopen-2025-101183
Verify or expand the search:
- PubMed search for NCT06829706
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Conventional olfactory training device
Trials testing the same drug.
- NCT06821828 — The Efficacy of Modified Olfactory Training for MCI High-Risk Individuals · NA · not yet recruiting
- NCT06837051 — The Effect of Modified Olfactory Training on Postoperative Olfactory Dysfunction in Patients With CRS · NA · not yet recruiting
Other recruiting trials for Olfactory Dysfunction
Currently open trials in the same condition.
- NCT06733636 — Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults · NA · recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
Other Peking University Third Hospital trials
Trials by the same sponsor.
- NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
- NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
- NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
- NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
- NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06829706 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
- Last refreshed: 17 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06829706.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing